# DefEYE and Celularity Announce Exclusive License and Manufacturing Partnership

> partnership · REPORTED · 2025-10-30

Celularity granted DefEYE an exclusive sublicense to its ophthalmic biologics portfolio including Biovance and Interfyl, and will serve as exclusive contract manufacturer, supporting DefEYE's commercialization of decellularized biologic eye-care solutions.

- Company: DefEYE
- Sector: medical devices
- Primary source: https://finance.yahoo.com/news/celularity-defeye-inc-partner-advance-120000336.html

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.